Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perry

Showing results (301-310 of 303) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 303 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2007
Guidelines on the standards for the training of specialised health professionals dealing with breast cancerL Cataliotti, C De Wolf, R Holland, et al.
Micropublication Biology|January 21, 2021
<i>B.2.16</i> is a non-lethal modifier of the <i>Dark</i> mosaic eye phenotype in <i>Drosophila melanogaster</i>Alysia D Vrailas-Mortimer, Nitish Aggarwal, Neha N Ahmed, et al.
Pageof 31

Showing results (301-310 of 303) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 303 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2007
Guidelines on the standards for the training of specialised health professionals dealing with breast cancerL Cataliotti, C De Wolf, R Holland, et al.
Micropublication Biology|January 21, 2021
<i>B.2.16</i> is a non-lethal modifier of the <i>Dark</i> mosaic eye phenotype in <i>Drosophila melanogaster</i>Alysia D Vrailas-Mortimer, Nitish Aggarwal, Neha N Ahmed, et al.
Pageof 31